ESTRO 36 Programme book and exhibition guide

A. Gulyban (Belgium), P. Berkovic, F. Lakosi, J. Hermesse, P.A. Coucke, V. Baart, D. Dechambre

OC-0263

SUNDAY 7 MAY 2017

10:40 > Assessment of Atlas based auto-segmentation in Breast Contouring P.H. Fok (Hong Kong SAR China), W.K. Fung, C.H.P. Ho, G. Chiu 10:50 > Evaluating variability of contouring using ESTRO guidelines for elective breast cancer radiotherapy D. Megias (UK), M. Sydenham, D. Wheatley, M. Maclennan, E. Spezi, A.M. Brunt 11:00 > Motion specific target delineation significantly reduce treated volumes in liver SBRT J. Wielaard (The Netherlands), C.H. Slump, K. Muller, A.W.H. Minken, H. Westendorp 11:10 > Automatic contour propagation of breast and heart for re-planning in breast cancer radiotherapy 11:20 > Volumetric comparison between PET/CT and CT simulation for target delineation in esophageal cancer E. Jimenez-Jimenez (Spain), P. Mateos, N. Aymar, I. Ortiz, R. Roncero, M. Vidal, M. Gimenez, F. Romero, S. Sabater G.G. Sikkes (The Netherlands), L.T.C. Meijers, A.N.T.J. Kotte, I.E. Van Dam, B. Van Asselen, H.J.G.D. Van den Bongard

OC-0264

OC-0265

OC-0266

OC-0267

OC-0268

MULTIDISCIPLINARY TUMOUR BOARD Lymphoma 10:30 - 11:30 | LEHAR 4 Chair: L. Specht (Denmark) ESTRO Fellow: B. De Bari (France) Panellist: M. Mayerhöfer (Austria) Panellist: U. Jäger (Austria) Panellist: I. Simonitsch-Klupp (Austria)

PROFFERED PAPERS

Prostate 2 10:30 - 11:30 | STOLZ 1-2 Chair: R. Alonzi (UK) Chair: H. Westerveld (The Netherlands)

10:30 > Single Dose Compared to Fractionated High-Dose Rate Brachytherapy for Localised Prostate Cancer P. Hoskin (UK), A. Rojas, P. Ostler, R. Hughes, R. Alonzi, G. Lowe 10:40 > QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction:phase II trial

OC-0269

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

110

Made with